Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Pathways to Developing Personalized Treatment Regimens for Patients with Advanced Melanoma

Access Activity

Overview / Abstract:

No two patients with advanced melanoma are the same and tailoring treatment is vital. Immerse yourself in this interactive “choose your path” digital algorithm with expert perspectives to assist with the application of new guidelines and treatment options to optimize therapy.

Do you have questions about treating patients with advanced melanoma? Do you wonder…
• When to use immune checkpoint inhibitors (ICIs), and in which combinations?
• How to select among the growing number of treatment options according to patient characteristics?
• How should immune-related adverse events be managed?
• How the mechanisms of action of the variety of ICIs differ, and how they impact patient care?
• Are there recommendations for sequencing treatments in advanced melanoma?

Start your engaging learning experience now and find the answers to these questions and more!

Expiration

Apr 28, 2024

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online

Credits / Hours

2.0

Accreditation

ACCME, MIPS QPP

Presenters / Authors / Faculty

Hussein Tawbi, MD, PhD (Chair)
Professor, Department of Melanoma Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

April Salama, MD (Faculty)
Associate Professor of Medicine
Medical Oncology
Director of the Melanoma Program
Duke Cancer Institute
Duke University School of Medicine
Durham, NC

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Bristol Myers Squibb.

Keywords / Search Terms

ACHL Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map